Related references
Note: Only part of the references are listed.Combined control of the fibroblast contractile program by YAP and TAZ
Patrick A. Link et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2022)
Dopamine receptor D2 antagonism normalizes profibrotic macrophage-endothelial crosstalk in non-alcoholic steatohepatitis
Jie Qing et al.
JOURNAL OF HEPATOLOGY (2022)
Hippo signalling in the liver: role in development, regeneration and disease
Jacquelyn O. Russell et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)
Myofibroblast YAP/TAZ activation is a key in
Xiaolin He et al.
JCI INSIGHT (2022)
Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function
Masum M. Mia et al.
CARDIOVASCULAR RESEARCH (2022)
Emerging roles of the Hippo signaling pathway in modulating immune response and inflammation-driven tissue repair and remodeling
Masum M. Mia et al.
FEBS JOURNAL (2022)
KLF4 initiates sustained YAP activation to promote renal fibrosis in mice after ischemia-reperfusion kidney injury
Dan Xu et al.
ACTA PHARMACOLOGICA SINICA (2021)
Icariin attenuates bleomycin-induced pulmonary fibrosis by targeting Hippo/YAP pathway
Wenjing Du et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Resveratrol Inhibits Hepatic Stellate Cell Activation via the Hippo Pathway
Chunxue Li et al.
MEDIATORS OF INFLAMMATION (2021)
Regeneration Defects in Yap and Taz Mutant Mouse Livers Are Caused by Bile Duct Disruption and Cholestasis
Elisabeth Verboven et al.
GASTROENTEROLOGY (2021)
Lats2 promotes heart failure by stimulating p53-mediated apoptosis during pressure overload
Dan Shao et al.
SCIENTIFIC REPORTS (2021)
SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation
Natalie M. Landry et al.
BASIC RESEARCH IN CARDIOLOGY (2021)
Inhibition of YAP activation attenuates renal injury and fibrosis in angiotensin II hypertensive mice
Junjie Zhang et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2021)
Age-dependent alveolar epithelial plasticity orchestrates lung homeostasis and regeneration
Ian J. Penkala et al.
CELL STEM CELL (2021)
AAV-mediated YAP expression in cardiac fibroblasts promotes inflammation and increases fibrosis
Jamie Francisco et al.
SCIENTIFIC REPORTS (2021)
Yes-Associated Protein (Yap) Is Up-Regulated in Heart Failure and Promotes Cardiac Fibroblast Proliferation
Maryam Sharifi-Sanjani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease
Weijun Ou et al.
EBIOMEDICINE (2021)
Selective Targeting of Vascular Endothelial YAP Activity Blocks EndMT and Ameliorates Unilateral Ureteral Obstruction-Induced Kidney Fibrosis
Yafeng Ren et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Hepatocyte Stress Increases Expression of Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis
Meghan Mooring et al.
HEPATOLOGY (2020)
Yes-Associated Protein in Kupffer Cells Enhances the Production of Proinflammatory Cytokines and Promotes the Development of Nonalcoholic Steatohepatitis
Kyoungsub Song et al.
HEPATOLOGY (2020)
GPCR-induced YAP activation sensitizes fibroblasts to profibrotic activity of TGFβ1
Katarina Zmajkovicova et al.
PLOS ONE (2020)
TBK1 regulates YAP/TAZ and fibrogenic fibroblast activation
Aja Aravamudhan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)
Screening for YAP Inhibitors Identifies Statins as Modulators of Fibrosis
Daniela M. Santos et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)
Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis
Xiaobo Wang et al.
CELL METABOLISM (2020)
Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis
Jing-Yu Chen et al.
CHINESE MEDICAL JOURNAL (2020)
Sphingosine Kinase 1/S1P Signaling Contributes to Pulmonary Fibrosis by Activating Hippo/YAP Pathway and Mitochondrial Reactive Oxygen Species in Lung Fibroblasts
Long Shuang Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Exosomes derived from hucMSC attenuate renal fibrosis through CK1δ/β-TRCP-mediated YAP degradation
Cheng Ji et al.
CELL DEATH & DISEASE (2020)
YAP Activation in Renal Proximal Tubule Cells Drives Diabetic Renal Interstitial Fibrogenesis
Jianchun Chen et al.
DIABETES (2020)
YAP is essential for TGF-beta-induced retinal fibrosis in diabetic rats via promoting the fibrogenic activity of Muller cells
Wei Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice
Sarah Alsamman et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Caveolin1 and YAP drive mechanically induced mesothelial to mesenchymal transition and fibrosis
Raffaele Strippoli et al.
CELL DEATH & DISEASE (2020)
YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction
Masum M. Mia et al.
PLOS BIOLOGY (2020)
Blockade of Fibroblast YAP Attenuates Cardiac Fibrosis and Dysfunction Through MRTF-A Inhibition
Jamie Francisco et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)
Regeneration and repair in the healing lung
Andrew Lucas et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
Lovastatin attenuates angiotensin II induced cardiovascular fibrosis through the suppression of YAP/TAZ signaling
Pei Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells
Hai-xia Yu et al.
MOLECULAR IMMUNOLOGY (2019)
YAP, but Not RSPO-LGR4/5, Signaling in Biliary Epithelial Cells Promotes a Ductular Reaction in Response to Liver Injury
Lara Planas-Paz et al.
CELL STEM CELL (2019)
Single-Cell Analysis of the Liver Epithelium Reveals Dynamic Heterogeneity and an Essential Role for YAP in Homeostasis and Regeneration
Brian J. Pepe-Mooney et al.
CELL STEM CELL (2019)
Yap/Taz regulate alveolar regeneration and resolution of lung inflammation
Ryan LaCanna et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Pharmacological inhibition of Hippo pathway, with the novel kinase inhibitor XMU-MP-1, protects the heart against adverse effects during pressure overload
Efta Triastuti et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
A Homeostatic Arid1a-Dependent Permissive Chromatin State Licenses Hepatocyte Responsiveness to Liver-Injury-Associated YAP Signaling
Weiping Li et al.
CELL STEM CELL (2019)
Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury
Yuan Liu et al.
JOURNAL OF HEPATOLOGY (2019)
Hippo pathway deletion in adult resting cardiac fibroblasts initiates a cell state transition with spontaneous and self-sustaining fibrosis
Yang Xiao et al.
GENES & DEVELOPMENT (2019)
The Hippo Signaling Pathway in Cardiac Development and Diseases
Masum M. Mia et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis
Andrew J. Haak et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
The Hippo-YAP pathway regulates the proliferation of alveolar epithelial progenitors after acute lung injury
Chen Hu et al.
CELL BIOLOGY INTERNATIONAL (2019)
YAP1/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF
Yingzhun Chen et al.
CELL DEATH AND DIFFERENTIATION (2019)
Kindlin-2 Inhibits the Hippo Signaling Pathway by Promoting Degradation of MOB1
Jiagui Song et al.
CELL REPORTS (2019)
Antiapoptosis and Antifibrosis Effects of Qishen Granules on Heart Failure Rats via Hippo Pathway
Jian Zhang et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Oroxylin A prevents angiogenesis of LSECs in liver fibrosis via inhibition of YAP/HIF-1 signaling
Chenxi Zhang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury
Takanori Konishi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2018)
YAP/TAZ regulates TGF-beta/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts
Zhaoping Qin et al.
CELL COMMUNICATION AND SIGNALING (2018)
Deregulation of Hippo-TAZ pathway during renal injury confers a fibrotic maladaptive phenotype
Sandybell Anorga et al.
FASEB JOURNAL (2018)
Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells
Kuo Du et al.
GASTROENTEROLOGY (2018)
Pathogenesis of non-alcoholic fatty liver disease mediated by YAP
Ping Chen et al.
HEPATOLOGY INTERNATIONAL (2018)
Melatonin Protects against Lung Fibrosis by Regulating the Hippo/YAP Pathway
Xiaoguang Zhao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis
Tetsuo Toyama et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Idiopathic Pulmonary Fibrosis
David J. Lederer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Yap/Taz mediates mTORC2-stimulated fibroblast activation and kidney fibrosis
Yuan Gui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
EGF Receptor-Dependent YAP Activation Is Important for Renal Recovery from AKI
Jianchun Chen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Alternative splicing rewires Hippo signaling pathway in hepatocytes to promote liver regeneration
Sushant Bangru et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Idiopathic Pulmonary Fibrosis (IPF): An Overview
Shaney L. Barratt et al.
JOURNAL OF CLINICAL MEDICINE (2018)
YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis
Akiko Futakuchi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2018)
Active epithelial Hippo signaling in idiopathic pulmonary fibrosis
Jason J. Gokey et al.
JCI INSIGHT (2018)
Epicardial YAP/TAZ orchestrate an immunosuppressive response following myocardial infarction
Vimal Ramjee et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Yap/Taz Deletion in Gli+ Cell-Derived Myofibroblasts Attenuates Fibrosis
Ming Liang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Idiopathic pulmonary fibrosis
Luca Richeldi et al.
LANCET (2017)
Sav1 Loss Induces Senescence and Stat3 Activation Coinciding with Tubulointerstitial Fibrosis
Janet Y. Leung et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
Gaseous signalling molecule SO2 via Hippo-MST pathway to improve myocardial fibrosis of diabetic rats
Maojun Liu et al.
MOLECULAR MEDICINE REPORTS (2017)
Hippo pathway deficiency reverses systolic heart failure after infarction
John P. Leach et al.
NATURE (2017)
TAZ contributes to pulmonary fibrosis by activating profibrotic functions of lung fibroblasts
Satoshi Noguchi et al.
SCIENTIFIC REPORTS (2017)
Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling
NaveenKumar Perumal et al.
BIOCHIMIE (2017)
Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effector
Jing Xu et al.
CLINICAL SCIENCE (2016)
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
Xiaobo Wang et al.
CELL METABOLISM (2016)
YAP/TAZ Are Mechanoregulators of TGF-β-Smad Signaling and Renal Fibrogenesis
Stephen G. Szeto et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis
Katherine Martin et al.
NATURE COMMUNICATIONS (2016)
ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation
Kun Zhang et al.
SCIENTIFIC REPORTS (2016)
The Hippo-Salvador signaling pathway regulates renal tubulointerstitial fibrosis
Eunjeong Seo et al.
SCIENTIFIC REPORTS (2016)
MAPK-Mediated YAP Activation Controls Mechanical-Tension-Induced Pulmonary Alveolar Regeneration
Zhe Liu et al.
CELL REPORTS (2016)
Stiffening hydrogels for investigating the dynamics of hepatic stellate cell mechanotransduction during myofibroblast activation
Steven R. Caliari et al.
SCIENTIFIC REPORTS (2016)
Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis
Yan Xu et al.
JCI INSIGHT (2016)
YAP1 Is a Driver of Myofibroblast Differentiation in Normal and Diseased Fibroblasts
Bram Piersma et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis
Fei Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
Fa-Xing Yu et al.
CELL (2015)
Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Crumbs3-Mediated Polarity Directs Airway Epithelial Cell Fate through the Hippo Pathway Effector Yap
Aleksander D. Szymaniak et al.
DEVELOPMENTAL CELL (2015)
Hepatic Inflammation and Fibrosis: Functional Links and Key Pathways
Ekihiro Seki et al.
HEPATOLOGY (2015)
The Hippo pathway effector YAP controls mouse hepatic stellate cell activation
Inge Mannaerts et al.
JOURNAL OF HEPATOLOGY (2015)
Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease
Mariana Verdelho Machado et al.
JOURNAL OF HEPATOLOGY (2015)
Emerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancer
Dean Yimlamai et al.
JOURNAL OF HEPATOLOGY (2015)
Fibrosis - A Common Pathway to Organ Injury and Failure
Don C. Rockey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury
Andrew E. Vaughan et al.
NATURE (2015)
Signaling in fibrosis: TGF-beta, wNT, and YAP/TAZ converge
Bram Piersma et al.
FRONTIERS IN MEDICINE (2015)
Hippo Pathway Activity Influences Liver Cell Fate
Dean Yimlamai et al.
CELL (2014)
Yap Tunes Airway Epithelial Size and Architecture by Regulating the Identity, Maintenance, and Self-Renewal of Stem Cells
Rui Zhao et al.
DEVELOPMENTAL CELL (2014)
Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance
Tom Luedde et al.
GASTROENTEROLOGY (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Liver fibrosis and repair: immune regulation of wound healing in a solid organ
Antonella Pellicoro et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Type 2 alveolar cells are stem cells in adult lung
Christina E. Barkauskas et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Decoding cell death signals in liver inflammation
Catherine Brenner et al.
JOURNAL OF HEPATOLOGY (2013)
Yes-associated protein regulates the hepatic response after bile duct ligation
Haibo Bai et al.
HEPATOLOGY (2012)
Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition
Javier Milara et al.
THORAX (2012)
Fumarates Promote Cytoprotection of Central Nervous System Cells against Oxidative Stress via the Nuclear Factor (Erythroid-Derived 2)-Like 2 Pathway
Robert H. Scannevin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
Brett Ley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Hippo signaling: growth control and beyond
Georg Halder et al.
DEVELOPMENT (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
Bin Zhao et al.
NATURE CELL BIOLOGY (2011)
Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice
Dominic P. Del Re et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
Hai Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver
Li Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis
Kwang-Pyo Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene
Dawang Zhou et al.
CANCER CELL (2009)
The myofibroblast in wound healing and fibrocontractive diseases
G Gabbiani
JOURNAL OF PATHOLOGY (2003)
Share Paper
